3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
pembrolizumab
7
Nivolumab
7
Specimen Handling
6
Mitomycin
6
Magnetic Resonance Spectroscopy
6
Capecitabine
6
Radiotherapy
5
Fluorouracil
4
Drug Therapy
4
Biopsy
4
Radiation
3
Paclitaxel
3
Ipilimumab
3
Fluorodeoxyglucose F18
3
Carboplatin
3
dehydroftorafur
2
atezolizumab
2
aldesleukin
2
Tomography, X-Ray Computed
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Mitozytrex
2
Colonoscopy
2
CTLA-4 Antigen
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
spartalizumab
1
enzalutamide
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.